US Stock MarketDetailed Quotes
OTLKW Outlook Therapeutics Inc C/Wts 18/02/2022(To Pur Com) Ser A
- 0.000
- 0.0000.00%
Close Dec 20 09:30 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.000Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares0.05052wk High0.00P/B0Float Cap0.01052wk Low--Dividend TTM0Shs Float3.490Historical High--Div YieldTTM0.00%Amplitude0.010Historical Low--Avg Price1Lot Size
Outlook Therapeutics Inc C/Wts 18/02/2022(To Pur Com) Ser A Key Stats
EPS
According to the latest financial report of Outlook Therapeutics Inc C/Wts 18/02/2022(To Pur Com) Ser A, the latest earnings per share (TTM) for the company is --. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Outlook Therapeutics Inc C/Wts 18/02/2022(To Pur Com) Ser A's free cash flow? The latest report shows it as -10.99M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Outlook Therapeutics Inc C/Wts 18/02/2022(To Pur Com) Ser A shows that the company's current ratio is 3.88, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Outlook Therapeutics Inc C/Wts 18/02/2022(To Pur Com) Ser A, the quick ratio is 3.52, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Outlook Therapeutics Inc C/Wts 18/02/2022(To Pur Com) Ser A? The latest ROE figure is -54.14%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Outlook Therapeutics Inc C/Wts 18/02/2022(To Pur Com) Ser A, the total asset return on investment (ROA) is -28.50%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Outlook Therapeutics Inc C/Wts 18/02/2022(To Pur Com) Ser A's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Outlook Therapeutics Inc C/Wts 18/02/2022(To Pur Com) Ser A, the net profit margin is -172.48%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Heat List
US
Overall
Symbol
Price
% Chg
No Data